A. P. Rameswara Rao appointed National President of BDMAI
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
Subscribe To Our Newsletter & Stay Updated